Anti-glomerular basement membrane disease with exclusive renal impairment
Main Article Content
Article Details
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Alchi B, Griffiths M, Sivalingam M, Gallagher H, Sinha S. Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort. Nephrol Dial Transplant. 2015;30(5):814-21. Doi: 10.1093/ndt/gfu399
Gulati K, McAdoo SP. Anti–Glomerular Basement Membrane Disease. Rheum Dis Clin North Am. 2018;44(4):651-73. Doi: 10.1016/j.rdc.2018.06.011
Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5):603-6. Doi: Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides
McAdoo SP, Pusey CD. Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol. 2017;12(7):1162-72. Doi: 10.2215/CJN.01380217
Van Daalen EE, Jennette JC, McAdoo SP, Tam FWK, Pusey CD, Alba MA, et al. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis. Clin J Am Soc Nephrol. 2017;13(1):63-72. Doi: 10.2215/CJN.04290417









